Phosphoinositide 3 Kinase Inhibitor Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
PRLD | D | Prelude Therapeutics Incorporated | -1.05 | |
APLM | F | Apollomics Inc. | -0.43 | |
CRIS | F | Curis, Inc. | -7.54 | |
APTO | F | Aptose Biosciences, Inc. | -1.84 |
Related Industries: Biotechnology
Related Stock Lists:
Cancer
Biopharmaceutical
Solid Tumors
Acute Myeloid Leukemia
Clinical Medicine
Drugs
Lymphoma
Medicine
Non Small Cell Lung Cancer
Oncology
Protein Kinase Inhibitor
Small Molecule Therapies
Targeted Therapy
Advanced Non Small Cell Lung Cancer
Antineoplastic Drugs
Bacterial Infections
Bemcentinib
Blastoma
Breast Cancer
Cancer Cell
Related ETFs - A few ETFs which own one or more of the above listed Phosphoinositide 3 Kinase Inhibitor stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | D | Loncar Cancer Immunotherapy ETF | 1.28 | |
IWC | C | iShares Microcap ETF | 0.01 | |
IWM | C | iShares Russell 2000 ETF | 0.0 | |
SCHB | A | Schwab U.S. Broad Market ETF | 0.0 | |
HDG | B | ProShares Hedge Replication ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Cancer
Biopharmaceutical
Solid Tumors
Acute Myeloid Leukemia
Clinical Medicine
Drugs
Lymphoma
Medicine
Non Small Cell Lung Cancer
Oncology
Protein Kinase Inhibitor
Small Molecule Therapies
Targeted Therapy
Advanced Non Small Cell Lung Cancer
Antineoplastic Drugs
Bacterial Infections
Bemcentinib
Blastoma
Breast Cancer
Cancer Cell
- Phosphoinositide 3 Kinase Inhibitor
Phosphoinositide 3-kinase (PI3K) inhibitors are drugs that block the activity of the PI3K enzyme, which is involved in many cellular processes, including cell growth, proliferation, and survival. PI3K inhibitors are used to treat certain types of cancer, as they can help to slow or stop the growth of cancer cells.
Popular Now
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles